Description

Book Synopsis


Table of Contents

Contributors xiii

Preface xxi

Acknowledgements xxiii

Prefixes, suffixes and abbreviations xxiv

Chapter 1: Introduction to pharmacology 1

Suzanne Evans and Tanya Somani

Aim 1

Naming and classifying drugs 5

How drugs bring about their actions 6

How are we able to manipulate physiological function using drugs? 6

Receptors as sites of drug action 7

Enzymes as sites of drug action 7

Ion channels 7

Transport molecules 9

Selectivity of binding and its effect 11

The drug–body interaction is a dynamic process 11

Conclusion 14

Glossary 14

References 15

Further reading 15

Multiple-choice questions 15

Chapter 2: How to use pharmaceutical and prescribing reference guides 18

Nigel Conway and Jennifer Dod

Aim 18

Introduction 19

HCPC Standards of conduct, performance and ethics 19

HCPC Standards of proficiency for paramedics 20

Joint Royal Colleges Ambulance Liaison Committee (JRCALC) Clinical Practice Guidelines 21

JRCALC Update information 22

How to navigate the JRCALC Guidelines 23

JRCALC Pocket Book 30

JRCALC Guidelines digital application (app) 31

Useful additional resources 32

British National Formulary (BNF) 32

Monthly Index of Medical Specialities 33

Electronic Medicines Compendium (EMC) 34

Conclusion 34

Disclaimer 35

References 35

Further reading 35

Multiple-choice questions 35

Chapter 3: Legal and ethical issues 37

Claire Leader, Emma Senior, Deborah Flynn and Paul Younger

Aim 37

Introduction 38

The law 38

Ethical principles and theories 39

Regulatory bodies 43

Research 45

Conclusion 47

Glossary 47

References 48

Further reading 49

Multiple-choice questions 50

Chapter 4: Medicines management and the role of the paramedic 52

Annette Hand, Carol Wills and Paul Younger

Aim 52

Introduction 53

Medicines management 53

Manufacturing, marketing, procurement and sale 54

Selection 55

Supply 55

Patient-specific directions 56

Prescriptions 56

Patient Group Directions 56

Exemptions 57

Prescribing 59

Handling and administration 60

Special consideration: Controlled Drugs and critical medications 62

Groups requiring special considerations 63

Monitoring for side-effects 64

Medicines optimisation 64

Safety in medicines management 65

Storage and disposal 66

Conclusion 66

References 66

Further reading 68

Multiple-choice questions 68

Chapter 5: Pharmacodynamics and pharmacokinetics 70

Dan Davern

Aim 70

Introduction 70

Professional regulatory council 71

Programmes of education and training 71

Pharmacokinetics 71

The pharmacokinetic processes 71

Phase 1: absorption 72

Phase 2: distribution 76

Phase 3: metabolism (biotransformation) 77

Phase 4: elimination 79

Pharmacodynamics 81

Agonists and antagonists 82

Drug potency and efficacy 84

Therapeutic index 84

Adverse drug reactions 85

Conclusion 87

References 87

Further reading 87

Multiple-choice questions 88

Chapter 6: Drug formulations 90

Sarah Dineen-Griffin and Barbara C. Wimmer

Aim 90

Introduction 91

Routes of drug administration 91

Parenteral administration 92

Intravenous administration 92

Subcutaneous administration 93

Intramuscular administration 93

Intraosseous administration 95

Intrathecal administration 95

Intradermal administration 95

Formulations 97

Localised versus long-acting injectable formulations 97

Topical formulations 97

Inhaled formulations 99

Enteral formulations 101

Rectal formulations 105

Conclusion 105

Glossary 106

References 106

Further reading 108

Multiple-choice questions 108

Chapter 7: Adverse drug reactions 110

Matt Dixon

Aim 110

What is an adverse drug reaction? 110

Classification of adverse drug reactions 111

How prevalent are adverse drug reactions? 111

Who is more likely to experience adverse drug reactions? 112

Recognising signs and symptoms of adverse drug reactions 114

Anaphylaxis 114

Rashes and skin eruptions 115

Serum sickness 115

Renal disorders 115

Geriatric syndrome 116

Idiosyncratic reactions 117

Preventing adverse drug reactions 117

Managing adverse drug reactions 117

Reporting adverse drug reactions 119

Conclusion 122

References 122

Further reading 123

Multiple-choice questions 123

Chapter 8: Analgesics 125

Tom Mallinson

Aim 125

Pain and analgesia 125

Understanding and assessing pain 125

Why do we treat pain? 126

Psychology of pain 126

Physiology of pain 127

Pain transmission 127

Pain modulation 128

Types of pain 129

Assessment of pain 131

Approach to analgesia 132

Paracetamol 133

Non-steroidal anti-inflammatory drugs 133

Inhalational analgesia 136

Opioids 137

Antagonists 141

Atypical analgesics 142

Antidepressants and antiepileptics 143

Adjuncts to analgesia 143

Magnesium sulfate 143

Local anaesthetics 143

Conclusion 144

Glossary 145

References 146

Further reading 147

Multiple-choice questions 147

Chapter 9: Antibacterials 149

Dean Whiting, Deborah Flynn and Dawn Ball

Aim 149

Introduction 149

Language and terminology 150

Antibacterial mechanisms of action 150

Disruption of bacterial cell wall synthesis: beta-lactams 151

Interference in folate metabolism: sulfonamides, trimethoprim 151

Inhibition of bacterial DNA synthesis: quinolones 151

Inhibition of bacterial protein synthesis: tetracyclines, aminoglycosides, macrolides, chloramphenicol, lincosamides 151

Choosing the right treatment 151

Antimicrobial resistance 151

Preventing antimicrobial resistance 152

Antimicrobial stewardship (AMS) 153

Antibacterials by clinical use 153

Beta-lactams 153

Tetracyclines 157

Chloramphenicol 158

When administered in combination with phenytoin, monitor seizure pattern. Aminoglycosides 159

Macrolides 161

Lincosamides 162

Conclusion 163

References 163

Further reading 164

Multiple-choice questions 164

Chapter 10: Medications used in the cardiovascular system 167

Lisa Clegg and Fraser Russell

Aim 167

Cardiovascular diseases 167

Hypertension and heart failure 168

Management of hypertension and heart failure 168

Acute coronary Syndrome (ACS) 173

Management of acute coronary syndrome 173

Conclusion 177

Glossary 177

References 178

Further reading 179

Multiple-choice questions 180

Chapter 11: Medications used in the renal system 182

Anthony Kitchener

Aim 182

Introduction 183

Acute kidney injury 183

Chronic kidney disease 185

Management of CKD 185

Electrolyte abnormalities resulting from poor renal function 187

Hyponatraemia (low serum sodium) 187

Hypokalaemia (low serum potassium) and hyperkalaemia (high serum potassium) 187

Urinary retention and incontinence 187

Drug-induced renal damage 188

Drugs that act on the renal system 188

Diuretics 188

Drugs used to treat urinary retention and urinary incontinence 193

Conclusion 195

Glossary 198

References 200

Further reading 201

Multiple-choice questions 201

Chapter 12: Medications and diabetes mellitus 203

Hayley Croft and Olivia Thornton

Aim 203

Introduction 204

Hormonal control of blood glucose 204

Monitoring diabetes 205

Measuring blood glucose 206

Measuring ketones 207

Drug use in diabetes 207

Insulin replacement therapy 207

Metformin 209

Sulfonylureas 209

Incretin mimetics 210

SGLT-2 inhibitors 210

Thiazolidinediones 211

Alpha-glucosidase inhibitors 211

Drug use in diabetic emergencies 211

Hypoglycaemic emergency 211

Hyperglycaemic emergency 216

Management of hyperglycaemia 218

Conclusion 219

Glossary 219

References 220

Multiple-choice questions 221

Chapter 13: Medications used in the respiratory system 224

Jason McKenna

Aim 224

Introduction 225

Anatomy and physiology 225

Nervous system control 226

Common respiratory emergencies 227

Asthma 227

Chronic obstructive pulmonary disease 230

Croup 231

Pneumonia 232

Pneumothorax 232

Pulmonary oedema 233

Classes of medications 234

Bronchodilators 234

Diuretics 236

Nitrates 236

Steroids 237

Medical gases 238

Oxygen devices 238

Conclusion 239

Find out more 239

References 239

Further reading 241

Multiple-choice questions 241

Chapter 14: Medications used in the gastrointestinal system 243

George Bell-Starr and Ashley Ingram

Aim 243

Introduction 244

Anatomy and physiology of the gastrointestinal system 244

Nausea and vomiting 244

H1 receptor antagonists (antihistamines) 246

Dopamine (D2) receptor antagonists 246

Serotonin (5-HT3) receptor antagonists 246

Peptic ulcers 247

Helicobacter pylori infections 247

Non-steroidal anti-inflammatory drugs 248

Symptoms of peptic ulcer 248

Constipation 249

Laxatives 249

Gastro-oesophageal reflux disease 251

Drug interventions (patients with confirmed endoscope diagnosis) 252

Paramedic practice 252

Antidiarrhoeals 254

Inflammatory bowel disease (IBD) 255

Crohn’s disease 255

Ulcerative colitis 255

Drug treatment for inflammatory bowel disease 255

Conclusion 257

References 257

Multiple-choice questions 258

Chapter 15: Medication and the nervous system 261

Geoffrey Bench, Alastair Dolan, Lena Solanki, Paul Doherty, Charlotte White, Ricky Lawrence and Emma Beadle

Aim 261

Introduction 261

The nervous system 262

Parkinson disease and parkinsonism 262

Infections 264

Dementia 264

Drugs used in dementia 265

Cautions 266

Epilepsy 267

Antiepileptic medication 268

Psychogenic non-epileptic seizures (PNES) versus bilateral tonic clonic seizures (BTCS) 268

Emergency medication in the prehospital setting 268

Strokes (including transient ischaemic attacks) 270

Definition of a stroke and a transient ischaemic attack 271

Assessment of a stroke 271

Treatment 272

Conclusion 274

References 274

Further reading/resources 275

Multiple-choice questions 276

Chapter 16: Medications used in mental health 278

Liam Rooney

Aim 278

Introduction 278

Neurotransmitters 279

Antidepressants 280

Selective serotonin reuptake inhibitors 281

Monoamine oxidase inhibitors 282

Serotonin and noradrenaline reuptake inhibitors 283

Serotonin syndrome 283

Other atypical antidepressants 284

Anxiolytics 285

Pregabalin 285

Benzodiazepines 285

Buspirone 286

Beta-blockers 286

Hypnotics 286

Benzodiazepines 286

Z-drugs 287

Mood-stabilising medications 287

Lithium 287

Valproate 287

Antipsychotics 288

Antipsychotic-related side-effects 288

Other side-effects 289

Dementia 291

Acetylcholinesterase inhibitors 291

Memantine 292

Attention deficit-hyperactivity disorder 292

Stimulants 292

Non-stimulants 292

Conclusion 293

Find out more about these conditions 293

Glossary 293

References 294

Further reading 296

Resources 296

Multiple-choice questions 296

Chapter 17: Immunisations 299

Michael Fanner

Aim 299

Introduction 299

Understanding the fundamental epidemiological concepts and theories in preventing infectious diseases 300

Essential ways of examining infectious diseases 301

Becoming familiar with vaccine design to underpin clinical practice knowledge 302

Vaccine design 302

Appreciating public concerns in the acceptability and uptake of immunisations 303

Vaccine acceptability 307

Recognising the role of the paramedic in health promotion and immunisation administration 308

Immunisations as prescription-only medicines 308

Embedding immunisation history taking in clinical assessment 309

Conclusion 315

References 316

Further reading 317

Multiple-choice questions 317

Normal Values 319

Answers 323

Index 325

Fundamentals of Pharmacology for Paramedics

    Product form

    £38.90

    Includes FREE delivery

    RRP £40.95 – you save £2.05 (5%)

    Order before 4pm today for delivery by Fri 3 Jul 2026.

    A Paperback / softback by Ian Peate, Suzanne Evans, Lisa Clegg

    1 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Fundamentals of Pharmacology for Paramedics by Ian Peate

      Publisher: John Wiley and Sons Ltd
      Publication Date: 17/03/2022
      ISBN13: 9781119724285, 978-1119724285
      ISBN10: 1119724287

      Description

      Book Synopsis


      Table of Contents

      Contributors xiii

      Preface xxi

      Acknowledgements xxiii

      Prefixes, suffixes and abbreviations xxiv

      Chapter 1: Introduction to pharmacology 1

      Suzanne Evans and Tanya Somani

      Aim 1

      Naming and classifying drugs 5

      How drugs bring about their actions 6

      How are we able to manipulate physiological function using drugs? 6

      Receptors as sites of drug action 7

      Enzymes as sites of drug action 7

      Ion channels 7

      Transport molecules 9

      Selectivity of binding and its effect 11

      The drug–body interaction is a dynamic process 11

      Conclusion 14

      Glossary 14

      References 15

      Further reading 15

      Multiple-choice questions 15

      Chapter 2: How to use pharmaceutical and prescribing reference guides 18

      Nigel Conway and Jennifer Dod

      Aim 18

      Introduction 19

      HCPC Standards of conduct, performance and ethics 19

      HCPC Standards of proficiency for paramedics 20

      Joint Royal Colleges Ambulance Liaison Committee (JRCALC) Clinical Practice Guidelines 21

      JRCALC Update information 22

      How to navigate the JRCALC Guidelines 23

      JRCALC Pocket Book 30

      JRCALC Guidelines digital application (app) 31

      Useful additional resources 32

      British National Formulary (BNF) 32

      Monthly Index of Medical Specialities 33

      Electronic Medicines Compendium (EMC) 34

      Conclusion 34

      Disclaimer 35

      References 35

      Further reading 35

      Multiple-choice questions 35

      Chapter 3: Legal and ethical issues 37

      Claire Leader, Emma Senior, Deborah Flynn and Paul Younger

      Aim 37

      Introduction 38

      The law 38

      Ethical principles and theories 39

      Regulatory bodies 43

      Research 45

      Conclusion 47

      Glossary 47

      References 48

      Further reading 49

      Multiple-choice questions 50

      Chapter 4: Medicines management and the role of the paramedic 52

      Annette Hand, Carol Wills and Paul Younger

      Aim 52

      Introduction 53

      Medicines management 53

      Manufacturing, marketing, procurement and sale 54

      Selection 55

      Supply 55

      Patient-specific directions 56

      Prescriptions 56

      Patient Group Directions 56

      Exemptions 57

      Prescribing 59

      Handling and administration 60

      Special consideration: Controlled Drugs and critical medications 62

      Groups requiring special considerations 63

      Monitoring for side-effects 64

      Medicines optimisation 64

      Safety in medicines management 65

      Storage and disposal 66

      Conclusion 66

      References 66

      Further reading 68

      Multiple-choice questions 68

      Chapter 5: Pharmacodynamics and pharmacokinetics 70

      Dan Davern

      Aim 70

      Introduction 70

      Professional regulatory council 71

      Programmes of education and training 71

      Pharmacokinetics 71

      The pharmacokinetic processes 71

      Phase 1: absorption 72

      Phase 2: distribution 76

      Phase 3: metabolism (biotransformation) 77

      Phase 4: elimination 79

      Pharmacodynamics 81

      Agonists and antagonists 82

      Drug potency and efficacy 84

      Therapeutic index 84

      Adverse drug reactions 85

      Conclusion 87

      References 87

      Further reading 87

      Multiple-choice questions 88

      Chapter 6: Drug formulations 90

      Sarah Dineen-Griffin and Barbara C. Wimmer

      Aim 90

      Introduction 91

      Routes of drug administration 91

      Parenteral administration 92

      Intravenous administration 92

      Subcutaneous administration 93

      Intramuscular administration 93

      Intraosseous administration 95

      Intrathecal administration 95

      Intradermal administration 95

      Formulations 97

      Localised versus long-acting injectable formulations 97

      Topical formulations 97

      Inhaled formulations 99

      Enteral formulations 101

      Rectal formulations 105

      Conclusion 105

      Glossary 106

      References 106

      Further reading 108

      Multiple-choice questions 108

      Chapter 7: Adverse drug reactions 110

      Matt Dixon

      Aim 110

      What is an adverse drug reaction? 110

      Classification of adverse drug reactions 111

      How prevalent are adverse drug reactions? 111

      Who is more likely to experience adverse drug reactions? 112

      Recognising signs and symptoms of adverse drug reactions 114

      Anaphylaxis 114

      Rashes and skin eruptions 115

      Serum sickness 115

      Renal disorders 115

      Geriatric syndrome 116

      Idiosyncratic reactions 117

      Preventing adverse drug reactions 117

      Managing adverse drug reactions 117

      Reporting adverse drug reactions 119

      Conclusion 122

      References 122

      Further reading 123

      Multiple-choice questions 123

      Chapter 8: Analgesics 125

      Tom Mallinson

      Aim 125

      Pain and analgesia 125

      Understanding and assessing pain 125

      Why do we treat pain? 126

      Psychology of pain 126

      Physiology of pain 127

      Pain transmission 127

      Pain modulation 128

      Types of pain 129

      Assessment of pain 131

      Approach to analgesia 132

      Paracetamol 133

      Non-steroidal anti-inflammatory drugs 133

      Inhalational analgesia 136

      Opioids 137

      Antagonists 141

      Atypical analgesics 142

      Antidepressants and antiepileptics 143

      Adjuncts to analgesia 143

      Magnesium sulfate 143

      Local anaesthetics 143

      Conclusion 144

      Glossary 145

      References 146

      Further reading 147

      Multiple-choice questions 147

      Chapter 9: Antibacterials 149

      Dean Whiting, Deborah Flynn and Dawn Ball

      Aim 149

      Introduction 149

      Language and terminology 150

      Antibacterial mechanisms of action 150

      Disruption of bacterial cell wall synthesis: beta-lactams 151

      Interference in folate metabolism: sulfonamides, trimethoprim 151

      Inhibition of bacterial DNA synthesis: quinolones 151

      Inhibition of bacterial protein synthesis: tetracyclines, aminoglycosides, macrolides, chloramphenicol, lincosamides 151

      Choosing the right treatment 151

      Antimicrobial resistance 151

      Preventing antimicrobial resistance 152

      Antimicrobial stewardship (AMS) 153

      Antibacterials by clinical use 153

      Beta-lactams 153

      Tetracyclines 157

      Chloramphenicol 158

      When administered in combination with phenytoin, monitor seizure pattern. Aminoglycosides 159

      Macrolides 161

      Lincosamides 162

      Conclusion 163

      References 163

      Further reading 164

      Multiple-choice questions 164

      Chapter 10: Medications used in the cardiovascular system 167

      Lisa Clegg and Fraser Russell

      Aim 167

      Cardiovascular diseases 167

      Hypertension and heart failure 168

      Management of hypertension and heart failure 168

      Acute coronary Syndrome (ACS) 173

      Management of acute coronary syndrome 173

      Conclusion 177

      Glossary 177

      References 178

      Further reading 179

      Multiple-choice questions 180

      Chapter 11: Medications used in the renal system 182

      Anthony Kitchener

      Aim 182

      Introduction 183

      Acute kidney injury 183

      Chronic kidney disease 185

      Management of CKD 185

      Electrolyte abnormalities resulting from poor renal function 187

      Hyponatraemia (low serum sodium) 187

      Hypokalaemia (low serum potassium) and hyperkalaemia (high serum potassium) 187

      Urinary retention and incontinence 187

      Drug-induced renal damage 188

      Drugs that act on the renal system 188

      Diuretics 188

      Drugs used to treat urinary retention and urinary incontinence 193

      Conclusion 195

      Glossary 198

      References 200

      Further reading 201

      Multiple-choice questions 201

      Chapter 12: Medications and diabetes mellitus 203

      Hayley Croft and Olivia Thornton

      Aim 203

      Introduction 204

      Hormonal control of blood glucose 204

      Monitoring diabetes 205

      Measuring blood glucose 206

      Measuring ketones 207

      Drug use in diabetes 207

      Insulin replacement therapy 207

      Metformin 209

      Sulfonylureas 209

      Incretin mimetics 210

      SGLT-2 inhibitors 210

      Thiazolidinediones 211

      Alpha-glucosidase inhibitors 211

      Drug use in diabetic emergencies 211

      Hypoglycaemic emergency 211

      Hyperglycaemic emergency 216

      Management of hyperglycaemia 218

      Conclusion 219

      Glossary 219

      References 220

      Multiple-choice questions 221

      Chapter 13: Medications used in the respiratory system 224

      Jason McKenna

      Aim 224

      Introduction 225

      Anatomy and physiology 225

      Nervous system control 226

      Common respiratory emergencies 227

      Asthma 227

      Chronic obstructive pulmonary disease 230

      Croup 231

      Pneumonia 232

      Pneumothorax 232

      Pulmonary oedema 233

      Classes of medications 234

      Bronchodilators 234

      Diuretics 236

      Nitrates 236

      Steroids 237

      Medical gases 238

      Oxygen devices 238

      Conclusion 239

      Find out more 239

      References 239

      Further reading 241

      Multiple-choice questions 241

      Chapter 14: Medications used in the gastrointestinal system 243

      George Bell-Starr and Ashley Ingram

      Aim 243

      Introduction 244

      Anatomy and physiology of the gastrointestinal system 244

      Nausea and vomiting 244

      H1 receptor antagonists (antihistamines) 246

      Dopamine (D2) receptor antagonists 246

      Serotonin (5-HT3) receptor antagonists 246

      Peptic ulcers 247

      Helicobacter pylori infections 247

      Non-steroidal anti-inflammatory drugs 248

      Symptoms of peptic ulcer 248

      Constipation 249

      Laxatives 249

      Gastro-oesophageal reflux disease 251

      Drug interventions (patients with confirmed endoscope diagnosis) 252

      Paramedic practice 252

      Antidiarrhoeals 254

      Inflammatory bowel disease (IBD) 255

      Crohn’s disease 255

      Ulcerative colitis 255

      Drug treatment for inflammatory bowel disease 255

      Conclusion 257

      References 257

      Multiple-choice questions 258

      Chapter 15: Medication and the nervous system 261

      Geoffrey Bench, Alastair Dolan, Lena Solanki, Paul Doherty, Charlotte White, Ricky Lawrence and Emma Beadle

      Aim 261

      Introduction 261

      The nervous system 262

      Parkinson disease and parkinsonism 262

      Infections 264

      Dementia 264

      Drugs used in dementia 265

      Cautions 266

      Epilepsy 267

      Antiepileptic medication 268

      Psychogenic non-epileptic seizures (PNES) versus bilateral tonic clonic seizures (BTCS) 268

      Emergency medication in the prehospital setting 268

      Strokes (including transient ischaemic attacks) 270

      Definition of a stroke and a transient ischaemic attack 271

      Assessment of a stroke 271

      Treatment 272

      Conclusion 274

      References 274

      Further reading/resources 275

      Multiple-choice questions 276

      Chapter 16: Medications used in mental health 278

      Liam Rooney

      Aim 278

      Introduction 278

      Neurotransmitters 279

      Antidepressants 280

      Selective serotonin reuptake inhibitors 281

      Monoamine oxidase inhibitors 282

      Serotonin and noradrenaline reuptake inhibitors 283

      Serotonin syndrome 283

      Other atypical antidepressants 284

      Anxiolytics 285

      Pregabalin 285

      Benzodiazepines 285

      Buspirone 286

      Beta-blockers 286

      Hypnotics 286

      Benzodiazepines 286

      Z-drugs 287

      Mood-stabilising medications 287

      Lithium 287

      Valproate 287

      Antipsychotics 288

      Antipsychotic-related side-effects 288

      Other side-effects 289

      Dementia 291

      Acetylcholinesterase inhibitors 291

      Memantine 292

      Attention deficit-hyperactivity disorder 292

      Stimulants 292

      Non-stimulants 292

      Conclusion 293

      Find out more about these conditions 293

      Glossary 293

      References 294

      Further reading 296

      Resources 296

      Multiple-choice questions 296

      Chapter 17: Immunisations 299

      Michael Fanner

      Aim 299

      Introduction 299

      Understanding the fundamental epidemiological concepts and theories in preventing infectious diseases 300

      Essential ways of examining infectious diseases 301

      Becoming familiar with vaccine design to underpin clinical practice knowledge 302

      Vaccine design 302

      Appreciating public concerns in the acceptability and uptake of immunisations 303

      Vaccine acceptability 307

      Recognising the role of the paramedic in health promotion and immunisation administration 308

      Immunisations as prescription-only medicines 308

      Embedding immunisation history taking in clinical assessment 309

      Conclusion 315

      References 316

      Further reading 317

      Multiple-choice questions 317

      Normal Values 319

      Answers 323

      Index 325

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account